EXACT platform
Search documents
Neurogene (NasdaqGM:NGNE) FY Earnings Call Presentation
2026-01-14 15:30
EVERY BREAKTHROUGH BEGINS WITH BELIEF 44th Annual J. P. Morgan Healthcare Conference January 2026 Rachel McMinn, Ph.D. Founder and Chief Executive Officer Disclaimer Forward Looking Statements Industry and Market Data Certain information contained in this Presentation relates to or is based on studies, publications, surveys and Neurogene's own internal estimates and research. In this Presentation, Neurogene relies on, and refers to, publicly available information and statistics regarding market participants ...